WO2001053455A3 - Novel nucleic acids and polypeptides - Google Patents
Novel nucleic acids and polypeptides Download PDFInfo
- Publication number
- WO2001053455A3 WO2001053455A3 PCT/US2000/035017 US0035017W WO0153455A3 WO 2001053455 A3 WO2001053455 A3 WO 2001053455A3 US 0035017 W US0035017 W US 0035017W WO 0153455 A3 WO0153455 A3 WO 0153455A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acids
- polypeptides
- novel nucleic
- novel
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002395736A CA2395736A1 (en) | 1999-12-23 | 2000-12-22 | Novel nucleic acids and polypeptides |
EP00990304A EP1254256A4 (en) | 1999-12-23 | 2000-12-22 | Novel nucleic acids and polypeptides |
AU27348/01A AU2734801A (en) | 1999-12-23 | 2000-12-22 | Novel nucleic acids and polypeptides |
US10/296,115 US20040053248A1 (en) | 2000-12-22 | 2000-12-22 | Novel nucleic acids and polypeptides |
US10/128,558 US20040219521A1 (en) | 2000-01-21 | 2002-04-22 | Novel nucleic acids and polypeptides |
US10/243,552 US20030224379A1 (en) | 2000-01-21 | 2002-09-12 | Novel nucleic acids and polypeptides |
US10/302,689 US20080050393A1 (en) | 1998-12-03 | 2002-11-22 | Novel nucleic acids and polypeptides |
US10/496,905 US20050192215A1 (en) | 2000-01-21 | 2002-12-02 | Methods and materials relating to novel polypeptides and polynucleotides |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47127599A | 1999-12-23 | 1999-12-23 | |
US09/471,275 | 1999-12-23 | ||
US48872500A | 2000-01-21 | 2000-01-21 | |
US09/488,725 | 2000-01-21 | ||
US55231700A | 2000-04-25 | 2000-04-25 | |
US09/552,317 | 2000-04-25 | ||
US09/596,196 US6586390B1 (en) | 2000-01-21 | 2000-06-17 | Methods and materials relating to novel prothrombinase-like polypeptides and polynucleotides |
US09/653,274 US6635742B1 (en) | 2000-01-25 | 2000-08-31 | Antibodies specific for semaphorin-like polypeptides |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US55231700A Continuation-In-Part | 1999-12-23 | 2000-04-25 | |
PCT/US2001/002687 Continuation-In-Part WO2001054477A2 (en) | 1998-12-03 | 2001-01-25 | Novel nucleic acids and polypeptides |
Related Child Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US549901A Continuation-In-Part | 2000-01-21 | 2001-12-03 | |
US8464302A Continuation-In-Part | 1998-12-03 | 2002-02-26 | |
US10/128,558 Continuation-In-Part US20040219521A1 (en) | 2000-01-21 | 2002-04-22 | Novel nucleic acids and polypeptides |
US10/243,552 Continuation-In-Part US20030224379A1 (en) | 2000-01-21 | 2002-09-12 | Novel nucleic acids and polypeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001053455A2 WO2001053455A2 (en) | 2001-07-26 |
WO2001053455A3 true WO2001053455A3 (en) | 2002-05-02 |
Family
ID=27541704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/035017 WO2001053455A2 (en) | 1998-12-03 | 2000-12-22 | Novel nucleic acids and polypeptides |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2001053455A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8958881B2 (en) | 2005-08-19 | 2015-02-17 | Brainsgate Ltd. | Neuroprotective electrical stimulation |
US9233245B2 (en) | 2004-02-20 | 2016-01-12 | Brainsgate Ltd. | SPG stimulation |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020137890A1 (en) | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US7344880B2 (en) | 1998-04-24 | 2008-03-18 | Genentech, Inc. | Nucleic acid encoding PRO9912 polypeptides |
US7414112B2 (en) | 1998-10-08 | 2008-08-19 | Genentech, Inc. | Antibodies to PRO1550 polypeptides |
PT1632499E (en) * | 1999-03-08 | 2007-09-11 | Genentech Inc | Gene sequences amplified in tumours and their diagnostic uses |
US7083791B2 (en) | 1999-03-25 | 2006-08-01 | Genesis Research & Development Corporation Limited | Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides |
US6242419B1 (en) * | 1999-03-25 | 2001-06-05 | Genesis Research & Development Corporation Ltd. | Compositions isolated from stromal cells and methods for their use |
US7282570B2 (en) | 1999-04-20 | 2007-10-16 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
WO2000073468A1 (en) | 1999-05-28 | 2000-12-07 | Immunex Corporation | Novel murine and human kinases |
US6617147B2 (en) | 2000-04-25 | 2003-09-09 | Lexicon Genetics Incorporated | Human kinase proteins and polynucleotides encoding the same |
US7083944B1 (en) * | 1999-10-27 | 2006-08-01 | Millennium Pharmaceuticals, Inc. | Molecules of the card-related protein family and uses thereof |
EP1666494A1 (en) * | 1999-12-01 | 2006-06-07 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US7307153B2 (en) | 1999-12-23 | 2007-12-11 | Genentech, Inc. | Antibodies that bind PRO9912 |
US7164001B2 (en) | 2000-01-20 | 2007-01-16 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
AU2001274923A1 (en) * | 2000-05-23 | 2001-12-03 | Lexicon Genetics Incorporated | Novel human thrombospondin-like proteins and polynucleotides encoding the same |
AU2001264819A1 (en) * | 2000-05-26 | 2001-12-11 | Indiana University Advanced Research And Technology Institute | Placc, a novel human c-c chemokine isolated from placenta |
US20020019028A1 (en) * | 2000-06-13 | 2002-02-14 | Kabir Chaturvedi | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
US7094587B2 (en) | 2000-06-27 | 2006-08-22 | Millennium Pharmaceuticals, Inc. | 16002 Molecules and uses therefor |
WO2002002771A2 (en) * | 2000-07-05 | 2002-01-10 | Eli Lilly And Company | Human sparc-homologous (hsparc-h1) gene and methods and uses thereof |
WO2002010217A2 (en) | 2000-08-02 | 2002-02-07 | The Johns Hopkins University | Endothelial cell expression patterns |
US7258855B2 (en) | 2000-09-19 | 2007-08-21 | Kyowa Hakko Kogyo Co., Ltd. | Polypeptides having phospholipase A2 activity |
US20020137170A1 (en) * | 2000-09-26 | 2002-09-26 | Ceptyr, Inc. | DSP-16 dual-specificity phosphatase |
JP2004524819A (en) * | 2000-10-04 | 2004-08-19 | キュラジェン コーポレイション | Novel proteins and nucleic acids encoding the same and antibodies against these proteins |
US6911336B2 (en) | 2000-10-18 | 2005-06-28 | Immunex Corporation | GNK interacting amino acid decarboxylase and methods of use thereof |
US20040171109A1 (en) * | 2000-11-10 | 2004-09-02 | Dominik Haudenschild | IL-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage |
IL155653A0 (en) | 2000-12-20 | 2003-11-23 | Bristol Myers Squibb Co | Polynucleotides encoding human phosphatases |
US20020102637A1 (en) * | 2000-12-21 | 2002-08-01 | Chunhua Yan | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
IL159015A0 (en) | 2001-05-25 | 2004-05-12 | Genset Sa | Polypeptides, their preparation and use |
US20030135035A1 (en) * | 2001-08-09 | 2003-07-17 | Mark Shannon | Human ZZAP1 protein |
EP1423415A4 (en) * | 2001-08-17 | 2005-04-06 | Incyte Genomics Inc | Intracellular signaling molecules |
JP3740043B2 (en) * | 2001-09-14 | 2006-01-25 | アテナ ダイアグナスティクス,インコーポレイテッド | Diagnosis and treatment of spinocerebellar degeneration (EAOH) based on aprataxin gene |
EP1428877A4 (en) * | 2001-09-17 | 2004-11-17 | Takeda Chemical Industries Ltd | Novel protein and dna thereof |
US20050123925A1 (en) | 2002-11-15 | 2005-06-09 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
EP1440089A2 (en) * | 2001-11-01 | 2004-07-28 | Amersham plc | Human angiomotin-like protein 1 |
US7151162B2 (en) | 2001-12-06 | 2006-12-19 | The University Of Children's Hospital Of Both Cantons Of Basel | Nuclear protein |
AU2003217693A1 (en) * | 2002-02-22 | 2003-09-09 | Board Of Trustees Of The University Of Illinois | Beta chain-associated regulator of apoptosis |
US7662924B2 (en) | 2002-02-22 | 2010-02-16 | The Board Of Trustees Of The University Of Illinois | Beta chain-associated regulator of apoptosis |
EP1483381A2 (en) * | 2002-03-14 | 2004-12-08 | Exonhit Therapeutics S.A. | Variants of human kallikrein-2 and kallikrein-3 and uses thereof |
US20060088835A1 (en) * | 2002-04-05 | 2006-04-27 | Pickard Benjamin S | Schizophrenia associated genes |
NZ535925A (en) * | 2002-04-16 | 2008-06-30 | Genentech Inc | An isolated antibody that binds to a particular polypeptide |
EP2305710A3 (en) | 2002-06-03 | 2013-05-29 | Genentech, Inc. | Synthetic antibody phage libraries |
CA2491083A1 (en) * | 2002-06-28 | 2004-01-08 | Imclone Systems Incorporated | Novel polynucleotide and polypeptide sequences and uses thereof |
JP2006508644A (en) * | 2002-08-14 | 2006-03-16 | エルジー・ライフ・サイエンシーズ・リミテッド | Gastric cancer-related gene family |
US7829503B2 (en) | 2003-03-27 | 2010-11-09 | Ptc Therapeutics, Inc. | Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-fungal agents |
EP1613158A4 (en) | 2003-03-27 | 2007-08-22 | Ptc Therapeutics Inc | METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-PROLIFERATIVE AGENTS |
DE04777457T1 (en) | 2003-07-02 | 2008-08-14 | Ptc Therapeutics, Inc. | RNA PROCESSING PROTEIN COMPLEXES AND USES THEREOF |
US20070202567A1 (en) * | 2003-09-27 | 2007-08-30 | Bayer Healthcare Ag | Diagnostics And Therapeutics For Diseases Associated With Arginyl Aminopeptidase Rnpep (Rnpep) |
US8010189B2 (en) | 2004-02-20 | 2011-08-30 | Brainsgate Ltd. | SPG stimulation for treating complications of subarachnoid hemorrhage |
NZ552956A (en) | 2004-07-20 | 2010-03-26 | Genentech Inc | Inhibitors of angiopoietin-like 4 protein (ANGPTL4), combinations, and their use for treating cancer |
US8604185B2 (en) | 2004-07-20 | 2013-12-10 | Genentech, Inc. | Inhibitors of angiopoietin-like 4 protein, combinations, and their use |
BRPI0513477A (en) | 2004-07-20 | 2008-05-06 | Genentech Inc | Angiotensin-like protein 4 compositions and processes |
DE102004059781A1 (en) * | 2004-12-10 | 2006-06-22 | Sanofi-Aventis Deutschland Gmbh | Use of serum / glucocorticoid-regulated kinase |
US9540427B2 (en) * | 2007-05-30 | 2017-01-10 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Peptide-based stat inhibitor |
BRPI1014858A2 (en) | 2009-03-30 | 2017-03-28 | Acceleron Pharma Inc | "bmp-alk3 antagonists and uses to promote bone growth" |
EP2878335B1 (en) | 2013-11-10 | 2018-01-03 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
US10271907B2 (en) | 2015-05-13 | 2019-04-30 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
EP3902917A4 (en) * | 2018-12-27 | 2022-11-30 | bioAffinity Technologies, Inc. | Compositions and methods for treating cancer |
-
2000
- 2000-12-22 WO PCT/US2000/035017 patent/WO2001053455A2/en not_active Application Discontinuation
Non-Patent Citations (3)
Title |
---|
DATABASE EST [online] NATIONAL HUMAN GENOME INSTITUTE, (BETHESDA, MD, USA); 13 October 1999 (1999-10-13), JIA ET AL.: "SGAP: The skeletal genome anatomy project", XP002944982, Database accession no. AW068570 * |
See also references of EP1254256A4 * |
WATSON ET AL.: "The science used in the recombinant DNA industry. Recombinant DNA; A short course", 1983, W.H. FREEMAN AND COMPANY, NEW YORK, XP002944983 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9233245B2 (en) | 2004-02-20 | 2016-01-12 | Brainsgate Ltd. | SPG stimulation |
US8958881B2 (en) | 2005-08-19 | 2015-02-17 | Brainsgate Ltd. | Neuroprotective electrical stimulation |
Also Published As
Publication number | Publication date |
---|---|
WO2001053455A2 (en) | 2001-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001053312A8 (en) | Novel nucleic acids and polypeptides | |
WO2001053455A3 (en) | Novel nucleic acids and polypeptides | |
WO2001075067A8 (en) | Novel nucleic acids and polypeptides | |
WO2001057188A3 (en) | Novel nucleic acids and polypeptides | |
WO2001057190A3 (en) | Novel nucleic acids and polypeptides | |
WO2002022660A3 (en) | Novel nucleic acids and polypeptides | |
WO2001066689A3 (en) | Novel nucleic acids and polypeptides | |
WO2002031111A3 (en) | Novel nucleic acids and polypeptides | |
WO2001088088A3 (en) | Novel nucleic acids and polypeptides | |
WO2003054152A3 (en) | Novel nucleic acids and polypeptides | |
WO2003025148A3 (en) | Novel nucleic acids and polypeptides | |
WO2002070539A3 (en) | Novel nucleic acids and polypeptides | |
WO2003023013A3 (en) | Novel nucleic acids and polypeptides | |
WO2002081731A3 (en) | Novel nucleic acids and polypeptides | |
WO2002059260A3 (en) | Nucleic acids and polypeptides | |
WO2004009834A3 (en) | Novel nucleic acids and secreted polypeptides | |
WO2004080148A3 (en) | Novel nucleic acids and polypeptides | |
WO2003029271A3 (en) | Novel nucleic acids and polypeptides | |
WO2002018424A3 (en) | Nucleic acids and polypeptides | |
WO2004087874A3 (en) | Novel nucleic acids and polypeptides | |
WO2001079449A3 (en) | Novel nucleic acids and polypeptides | |
WO2001002571A3 (en) | An interleukin-1 receptor antagonist and uses thereof | |
WO2003080795A8 (en) | Novel nucleic acids and secreted polypeptides | |
WO2002044340A3 (en) | Novel nucleic acids and polypeptides | |
WO2005049806A3 (en) | Novel nucleic acids and polypeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2395736 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000990304 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000990304 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10296115 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000990304 Country of ref document: EP |